Our vision is to be an innovative organisation that truly engages and enriches society through clinical trial awareness and participation. We are striving to make a global impact on overall clinical trial timelines and enable the industry to advance medical research swiftly.
Our mission is to automate the study start-up and patient recruitment processes using predictive technology to reduce inaccuracies, repetitive administrative headaches that study teams, sponsors and patients experience. Ultimately we want to have a direct impact on the overall time it takes for new and improved medicines to become available to those who need them.
Location: Australia, New South Wales, Sydney
Member count: 11-50
Total raised: $2.043389M
Investors 1
| Date | Name | Website |
| 30.09.2022 | BridgeLane... | bridgelane... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 05.09.2022 | Seed | $2.043389M | - | - |